Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.
Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.
Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.
Metaphore Biotechnologies is a firm that uses biomimicry and machine learning to unlock the revolutionary therapeutic.
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Omega Therapeutics offers a proprietary epigenomic programming platform.
Montai Health platform enables rapid and repeatable advancement of therapies across multiple diseases.
Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.
ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the ability to create therapeutics.
Vesalius Therapeutics is focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
Repertoire Immune Medicines is a clinical stage biotechnology company.
Rubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.
Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.
Sigilon Therapeutics is a biotech company that specializes in creating immune-privileged products for treating acute and chronic diseases.
Cygnal Therapeutics is a biotechnology company
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Sesen Bio is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
WikiCell Designs develops edible forms of packaging that enclose food or drinks in ways similar to how nature protects them.
Flagship Pioneering has invested in 70 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Flagship Pioneering's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 17 different industry categories.
Among tracked funding rounds, Rubius Therapeutics received $200.0M in a Post Ipo Equity round. Flagship Pioneering's total known invested capital is $4.9B.
Flagship Pioneering's average investment size is $73.8M across its portfolio of 70 companies.
Recent Flagship Pioneering portfolio additions include Alltrna, Evelo Biosciences, Empress Therapeutics, Metaphore Biotechnologies, Ring Therapeutics. These companies were founded in 2020 or later.